pharmaphorum

FEBRUARY 2, 2022

Pharming has taken a step closer to getting a second product to market, after its rare disease therapy leniolisib met its objectives in a pivotal trial, setting up regulatory filings in the coming months. For comparison, Takeda reported sales of around $415 million in the first six months of the 2021-22 fiscal year.

Trials 52

Trials Drugs Sales Generic Drugs 52

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely.

Development 242

Development Bioequivalency Generic Drugs Production 242

The Pharma Data

MAY 6, 2021

Moderna lifts COVID-19 vaccine sales forecast to $19.2 Taking double Covid-19 hits, Merck writes off $170M for scrapped drug, highlights $600M in missed sales ( Endpoints ). In Belgium, too many clinical trial sponsors waffle about reporting required results ( STAT ). OcuWho? .

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

pharmaphorum

OCTOBER 28, 2021

There were also numerically fewer deaths with the antidepressant – 17 out of 741 treated with fluvoxamine and 25 out of 756 allocated to placebo – in the TOGETHER trial, which has now been published in The Lancet. The post Generic pill could be alternative to oral antivirals in COVID-19 appeared first on.

Generic Drugs 98

Generic Drugs Sales Licensing Licensing 98

pharmaphorum

MARCH 16, 2022

Viatris’ generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been cleared for the same indications as the brand, namely maintenance treatment for asthma and chronic obstructive pulmonary disease (COPD).

FDA Approval 59

FDA Approval Generic Drugs Marketing Drug Delivery 59

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. The company is comprised of several units, and the largest is Johnson & Johnson’s pharma unit which generated $52.56 billion in pharmaceutical sales from 2021. billion the drug generated in 2021. billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78